Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 3
2013 1
2014 1
2015 7
2016 9
2017 10
2018 12
2019 21
2020 14
2021 10
2022 4
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
A clinically applicable integrative molecular classification of meningiomas.
Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G. Nassiri F, et al. Nature. 2021 Sep;597(7874):119-125. doi: 10.1038/s41586-021-03850-3. Epub 2021 Aug 25. Nature. 2021. PMID: 34433969
Degenerative cervical myelopathy - update and future directions.
Badhiwala JH, Ahuja CS, Akbar MA, Witiw CD, Nassiri F, Furlan JC, Curt A, Wilson JR, Fehlings MG. Badhiwala JH, et al. Among authors: nassiri f. Nat Rev Neurol. 2020 Feb;16(2):108-124. doi: 10.1038/s41582-019-0303-0. Epub 2020 Jan 23. Nat Rev Neurol. 2020. PMID: 31974455 Review.
A molecularly integrated grade for meningioma.
Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, Aizer AA, Alexander BM, Ligon KL, Reardon DA, Wen PY, Al-Mefty O, Ligon AH, Dubuc AM, Beroukhim R, Claus EB, Dunn IF, Santagata S, Bi WL. Driver J, et al. Among authors: nassiri f. Neuro Oncol. 2022 May 4;24(5):796-808. doi: 10.1093/neuonc/noab213. Neuro Oncol. 2022. PMID: 34508644 Free PMC article.
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM, Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G. Nassiri F, et al. Nat Med. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. Epub 2023 May 15. Nat Med. 2023. PMID: 37188783 Free PMC article. Clinical Trial.
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP, Hegi ME, Stupp R, Aldape KD, Zadeh G. Mansouri A, et al. Among authors: nassiri f. Neuro Oncol. 2019 Feb 14;21(2):167-178. doi: 10.1093/neuonc/noy132. Neuro Oncol. 2019. PMID: 30189035 Free PMC article. Review.
The Epigenetic Landscape of Meningiomas.
Wang JZ, Nassiri F, Aldape K, von Deimling A, Sahm F. Wang JZ, et al. Among authors: nassiri f. Adv Exp Med Biol. 2023;1416:175-188. doi: 10.1007/978-3-031-29750-2_13. Adv Exp Med Biol. 2023. PMID: 37432627
Genomic Landscape of Meningiomas.
Wang JZ, Nassiri F, Mawrin C, Zadeh G. Wang JZ, et al. Among authors: nassiri f. Adv Exp Med Biol. 2023;1416:137-158. doi: 10.1007/978-3-031-29750-2_11. Adv Exp Med Biol. 2023. PMID: 37432625
Immune Profiling of Meningiomas.
Wang JZ, Nassiri F, Bi L, Zadeh G. Wang JZ, et al. Among authors: nassiri f. Adv Exp Med Biol. 2023;1416:189-198. doi: 10.1007/978-3-031-29750-2_14. Adv Exp Med Biol. 2023. PMID: 37432628 Review.
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Wang JZ, Patil V, Liu J, Dogan H, Tabatabai G, Yefet LS, Behling F, Hoffman E, Bunda S, Yakubov R, Kaloti R, Brandner S, Gao A, Cohen-Gadol A, Barnholtz-Sloan J, Skardelly M, Tatagiba M, Raleigh DR, Sahm F, Boutros PC, Aldape K; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G. Wang JZ, et al. Among authors: nassiri f. Acta Neuropathol. 2023 Jul;146(1):145-162. doi: 10.1007/s00401-023-02571-3. Epub 2023 Apr 24. Acta Neuropathol. 2023. PMID: 37093270 Free PMC article.
Advances in multidisciplinary therapy for meningiomas.
Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas. Brastianos PK, et al. Among authors: nassiri f. Neuro Oncol. 2019 Jan 14;21(Suppl 1):i18-i31. doi: 10.1093/neuonc/noy136. Neuro Oncol. 2019. PMID: 30649489 Free PMC article. Review.
105 results